RxDoctor Payments DataLook up a doctor →

David Rausher, MD

Gastroenterology · Decatur, GANPI 1588653976

Payments from drug & device makers

$906,505in general payments, 2019–2025

Across 514 payments — averaging $1763.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$156K
  • Braintree Laboratories, Inc.$154K
  • Janssen Research & Development, LLC$95K
  • Bristol Myers Squibb$94K
  • GSK$77K
  • Takeda Pharmaceuticals U.S.A., Inc.$53K
  • plus $278K from 36 others
$2,824in research payments, 2019–2025

Across 2 payments — averaging $1411.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$3K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$906,505 in reported general payments places this provider in the 95th percentile of 492 gastroenterology providers in Georgia.

See all gastroenterology providers in Georgia

Medicare billing

Part B allowed, 2024
$163,724
Medicare patients
145
Services billed
4,748

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Decatur

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →